170 views | 1 decade ago
Tony Gordon, Genesis Genomics Managing Director (US) and Lab Director (UK) shares his vision for better IVF clinical outcomes and increased pregnancy rates using next-generation sequencing (NGS). Discover...
366 views | 1 decade ago
Tony Gordon, Genesis Genomics Managing Director (US) and Lab Director (UK) discusses how the Illumina portfolio empowers reproductive health labs with its ability to run both pre-and postnatal tests...
412 views | 1 decade ago
Some people struggle more to lose weight than others. The Fat mass and obesity-associated (FTO) gene is the first gene identified by genome-wide association studies as a strong candidate for obesity-related...
1925 views | 1 decade ago
Francesco Fiorentino, Director of Genoma Molecular Genetics Laboratory, Rome, Italy, discusses the high-throughput, high-resolution advantages of next-generation sequencing for preimplantation genetic...
247 views | 1 decade ago
Highlights from the Illumina User Meeting at AGBT 2015.
1519 views | 1 decade ago
Francesco Fiorentino, Director of Genoma Molecular Genetics Laboratory, Rome, Italy, discusses the high-throughput, high-resolution advantages of next-generation sequencing http://technology.illumina.com/technology/next-generation-sequencing.html...
2570 views | 1 decade ago
The limitations of conventional library preparation methods are well known. At Illumina, we ve been collaborating with researchers and labs to develop a transformative, next-gen solution that promises...
5303 views | 1 decade ago
Introducing the NeoPrep System [ www.illumina.com/neoprep ] a radically simple solution that performs the complete library prep process, delivering sequencing-ready libraries, including quantification...